FDA monthly preview: Key October decisions to watch
-
By
-
Kathryn Wighton
-
September 25, 2026
-
5 min
By
Kathryn Wighton
September 25, 2026
by Abdirizak Ali Osman, Mari Hoff, Paul Jarle Mork, Vibeke Videm
June 25, 2026
A Geneva registry study points surgeons toward residual pain over functional limitation as the outcome that tracks patient satisfaction one year after hip or knee replacement.
June 19, 2026
In a small open-label randomized trial, 2 platelet-rich plasma injections were associated with greater 6-month improvements in pain and function than corticosteroid injection or oral aceclofenac among patients awaiting knee arthroplasty.
June 22, 2026